APPLICATION
ANDA071169
TYPE
ANDA
ORIGINAL APPROVAL
1988-06-16
LATEST ACTION
2002-12-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEDiscontinued
BUPIVACAINE HYDROCHLORIDE 0.5%, EPINEPHRINE 0.005MG/ML · INJECTABLE · INJECTION
Approval history
2002-12-20Manufacturing (CMC) · Supplement 8AP
1999-11-22Labeling · Supplement 7AP
1991-02-21Manufacturing (CMC) · Supplement 1AP
1990-10-03Labeling · Supplement 5AP
1990-05-04Labeling · Supplement 4AP
1988-06-16OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.